Press Releases
-
Spring Bank Announces Interim Top-Line Results from the First Cohort of the Phase 2 Trial Evaluating Low-Dose Inarigivir Plus Vemlidy® in Chronic Hepatitis B Patients
HOPKINTON, MA, UNITED STATES - Oct 17, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced interim top-line results at 12 weeks from the first cohort of the ongoing Phase 2 trial evaluating the safety, efficacy and pharmacodynamics of escalating doses (50mg, 200mg and 400mg) of the investigational compound inarigivir co-administered with Gilead Sciences Vemlidy® (tenofovir alafenamide 25mg) for the treatment of chronic hepatitis B virus (HBV) infection
Nov 18, 2019
-
Greenphire Demonstrates Continued Commitment to Global Sponsors and Sites; Participates in Two Leading European Clinical Trial Conferences and Hosts User Group in Poland
KING OF PRUSSIA, PA, UNITED STATES - Nov 18, 2019 - Greenphire, the global leader in financial workflow automation solutions for clinical trials, today announced its company executives will present at two of Europe's most important clinical trial conferences, the Central & Eastern European Site Symposium in Warsaw, Poland on Monday, November 18 and Clinical Trials Europe, in Barcelona, Spain on Thursday, November 21
Nov 18, 2019
-
Survey Findings Show Increase in Clinical Trial Results Transparency
JERSEY CITY, NJ, UNITED STATES - Nov 15, 2019 - TrialScope, the global leader in clinical trial transparency and disclosure compliance solutions, has released results from its 2nd Biennial Plain Language Summaries (PLS) Survey
Nov 15, 2019
-
Signant Health and ActiGraph simplify clinical trial activity and sleep monitoring for patients, sites, and sponsors with their new integration
PHILADELPHIA, PA, UNITED STATES - Nov 14, 2019 - Signant Health, formerly CRF Health and Bracket, is proud to announce that it has integrated its industry leading eCOA platform TrialMax®, with ActiGraphs CentrePoint system
Nov 14, 2019
-
Industry Leaders Convene in New York for EXTRA: TrialScope Transparency Experience
JERSEY CITY, NJ, UNITED STATES - Nov 7, 2019 - At the recent EXTRA: TrialScope Transparency Experience in New York City, TrialScope brought together pharmaceutical sponsors, patient advocacy organizations and other industry leaders for two days of presentations, workshops and networking
Nov 7, 2019
-
Signant Health Host 8th Annual eCOA Forum To Convene Clinical Operations and Outcomes Research Leaders Guiding the Future of Patient-Centric Technology
PHILADELPHIA, PA - Nov 7, 2019 - Signant Health is proud to host its 8th annual eCOA Forum, which convenes clinical operations and outcomes research leaders for the industry’s premier event focused on eCOA, eConsent, and patient-centric technology
Nov 7, 2019
-
Signant Health Proud to Sponsor the Philadelphia Walk to End Alzheimer’s in Nationwide Effort to Build Awareness, Raise Funds and Advance Research Towards a Cure.
PHILADELPHIA, PA - Nov 7, 2019 - Signant Health, formerly CRF Health and Bracket, announced today that it is sponsoring the Philadelphia Walk to End Alzheimers
Nov 7, 2019
-
Clinical Trials Laboratory Services Shows Donor Appreciation with Enhanced Services at its Blood Donation Centers
LONDON, UK - Nov 4, 2019 - Clinical Trials Laboratory Services (CTLS), a leading provider of human blood products and biological specimens to the research community, today announced that it has made several enhancements to the donor experience at its donor center in North West London, UK
Nov 4, 2019
-
Shimmer Receives CE Certification for its ECGmd Holter Monitor Electrocardiograph
CAMBRIDGE, MA - Nov 4, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced that ECGmd – its five-wire, four-lead holter monitor electrocardiograph (ECG) – is now a CE certified, Class IIa medical device under the Medical Device Directive (93/42/EEC)
Nov 4, 2019
-
Winners of the 2019 President’s Startup Challenge Announced, as The Pistoia Alliance Looks to the Future
BOSTON, MA, UNITED STATES - Oct 30, 2019 - The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, has announced the winners of the 2019 Presidents Startup Challenge at its annual member conference in Boston
Oct 30, 2019
-
TrialScope Acquires Clinical Trial Connect
JERSEY CITY, NJ, US - Oct 24, 2019 - TrialScope, the global leader in transparency and disclosure compliance solutions, has acquired Clinical Trial Connect, a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials
Oct 24, 2019
-
KCR Announces new Chief Technology Officer
BOSTON, MA, US - Oct 24, 2019 - KCR, an international clinical development solutions provider, has named Douglas Bain the organizations Chief Technology Officer
Oct 24, 2019
-
MR Solutions’ new preclinical imaging PET/CT range on display at EANM ‘19
GUILDFORD, UNITED KINGDOM - Oct 24, 2019 - MR Solutions has launched a complete range of advanced PET/CT preclinical imaging systems at EANM 19, (European Association of Nuclear Medicine) last week in Barcelona
Oct 24, 2019
-
Accumen Acquires Medical Imaging Post-Processing Company 3DR Laboratories
PHOENIX, AZ - Oct 22, 2019 - Accumen Inc., the leader in healthcare performance, today announced that it has acquired 3DR Laboratories, the largest and most respected 3D medical post-processing laboratory in the United States
Oct 22, 2019
-
As Demand for RBx Soars CluePoints Continues Global Expansion Alongside Further Award Wins
KING OF PRUSSIA, PA - Oct 22, 2019 - CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced major expansion as it bolsters its offering with two new larger offices to accommodate its growing family of employees and contractors
Oct 22, 2019
-
BioIVT Acquires PPA Research Group, Increasing its Ability to Support Drug Development, Cell and Gene Therapy Research
WESTBURY, NY - Oct 16, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired PPA Research Group, Inc
Oct 16, 2019
-
The University of Bristol Selects Signant Health’s TrialConsent® to Assess the Impact and Value of eConsent in an Oncology Trial
PHILADELPHIA, PA, UNITED STATES - Oct 14, 2019 - The National Institute for Health Research Bristol Biomedical Research Centre (NIHR Bristol BRC) at the University of Bristol has selected Signant Health, formerly CRF Health and Bracket, as its partner to provide electronic informed consent (eConsent) support for an oncology trial
Oct 14, 2019
-
Irish Clinical Research Team Selects Shimmer’s Verisense Continuous Monitoring Platform to Study Breast Cancer-related Fatigue
CAMBRIDGE, MA - Oct 10, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced that a team of researchers from Letterkenny Institute of Technology (LYIT) and Letterkenny University Hospital (LUH) will be using Shimmers Verisense continuous monitoring platform to study fatigue accurately in individuals with breast cancer
Oct 10, 2019
-
N-SIDE welcomes Wade Wirta as US Managing Director
LOUVAIN LA NEUVE, BELGIUM - Oct 9, 2019 - N-SIDE, a global software consulting company specializing in advanced analytics technologies, is pleased to welcome Wade Wirta as US Managing Director
Oct 10, 2019
-
Updated: Certara Launches BaseCase Data Studio, Enabling Pharma and MedTech Clients to Conduct Advanced Data Analyses During Value-based Product Discussions
PRINCETON, NJ - Oct 9, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of BaseCase Data Studio, the newest product for its BaseCase value communications platform
Oct 9, 2019
